Answer Prior Authorization Operations Case more questions on document For this project, please spend 1-2 hours creating a Google doc that outlines your a

Answer Prior Authorization Operations Case more questions on document For this project, please spend 1-2 hours creating a Google doc that outlines your answers to the questions below. If you have any questions, please reach out to us via email.Background on Prior AuthorizationPrior authorization is a procedure used by health insurance companies to determine if they will cover a prescribed medication. This process is aimed at ensuring the treatment is medically necessary and aligns with the insurer’s coverage policies. Unfortunately, this process can be time consuming and confusing to navigate for both patients and their providers.The general process is as follows:1. A healthcare provider prescribes medication for a patient.2. If the medication is not automatically covered under the patient’s insurance plan, a prior authorization request form must be submitted to the insurance company. The form requires detailed information about the patient’s medical condition and why this specific medication is necessary.

3. The insurance company reviews the request to assess the medical necessity of the medication and whether or not it should be covered under the patient’s specific policy. This process typically takes a few days, though some reviews are automated and are completed instantly.4. The insurance company either approves or denies the prior authorization request and responds via fax.        a. If approved, the patient’s medication will be covered by their insurance at the pharmacy.         b. If denied, the provider must decide if a change in medication is required or if they should “appeal” the insurance company’s decision by writing a letter about the need for coverage.Questions1. PA example scenario: Assume you are completing a PA for a chronic migraine patient who has been prescribed Emgality for the first time. The patient’s health insurance is United Healthcare.a. Emgality typically requires that patients complete step therapy requirements. Research and list out the step therapy requirements for this medication for the patient’s insurance.Include links to any references you used.b. In filling out the PA, you realize the documentation does not show that the patient hascompleted all step therapy requirements from the plan. Draft an email to the providerrequesting any additional information you think you need to complete a PA for Emgality.c. The patient has never had to go through a PA process before, so they don’t understandwhy their prescription is not ready yet or what current status is. Draft a text message explaining the situation of their Emgality prescription to the patient. Remember thattexts should be succinct while conveying the most important information2. Analyzing our PA operations: the chart below shows the average minutes spent by an operations associate on completing and submitting a prior authorization form (note data isillustrative). Clearly state any assumptions you are making.a. How many hours did it take to complete 100 PAs per day in January 2024 vs. April2024?b. How many Operations associates were required to handle these 100 PAs per day in January 2024 vs. April 2024? (assuming these operations associates were only workingon PAs) :

c. What do you think has driven the decrease in time per PA?d. What do you think time per PA will be in May 2024 and June 2024? Why? 

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and Ozempic have gained attention due to their efficacy in managing conditions such as type 2 diabetes and obesity. Discuss about similarities, differences, and clinical implications of these two new drugs. 

Bring in examples of advertising or of the supplements that promise dieting, fad diets, nutritional supplements to make hair regrow or to relieve stress,

Bring in examples of advertising or of the supplements that promise dieting, fad diets, nutritional supplements to make hair regrow or to relieve stress, or any of the numerous products that make promises to consumers. Which of the promises do you believe? DISCUSSION POST                                300 words (minimum) APA or

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and

The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and Ozempic have gained attention due to their efficacy in managing conditions such as type 2 diabetes and obesity. Discuss about similarities, differences, and clinical implications of these two new drugs. 

Case Study 1: Hypertension Management in a 50-Year-Old Patient Objective: Understand the pharmacologic treatment of hypertension, evaluate drug

Case Study 1: Hypertension Management in a 50-Year-Old Patient Objective: Understand the pharmacologic treatment of hypertension, evaluate drug interactions, and individualize care plans. Patient Profile: Age: 50 Gender: Male Height/Weight: 5’9”, 230 lbs Medical History: Hypertension (diagnosed 3 years ago), Type 2 Diabetes (well-controlled with metformin), elevated cholesterol Current Medications:

Patient-Centered Care and Health Information Technology [WLOs: 1, 2] [CLOs: 1, 3, 4, 6] Prior to beginning work on this discussion forum, Read Chapter 8

Patient-Centered Care and Health Information Technology [WLOs: 1, 2] [CLOs: 1, 3, 4, 6] Prior to beginning work on this discussion forum, Read Chapter 8 from your course textbook, McLaughlin and Kaluzny’s Continuous Quality Improvement in Health Care (5th ed.). Review the following articles: Artificial Intelligence and the Ongoing Need for Empathy,